Director S/holding-Replacemnt
Dechra Pharmaceuticals PLC
22 May 2002
The issuer has made the following amendment to the Directors Shareholding
announcement released on Tuesday 21 May at 13:37 under RNS No 2097W.
Boxes 15 and 16 for 'Simon Evans' (Director) should read 15: 663,000 and not
643,000 and 16: should read 1.32% and not 1.28% as previously stated.
All other details remain unchanged.
The full corrected version is shown below.
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
DECHRA PHARMACEUTICALS PLC
2) NAME OF DIRECTOR
MALCOLM DIAMOND
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
AS ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
AS ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
PURCHASE OF SHARES
7) Number of shares/amount of
stock acquired
5,000
8) (0.01%)
of issued Class
9) Number of shares/amount
of stock disposed
N/A
10) ( N/A %)
of issued Class
11) Class of security
ORDS OF 1P
12) Price per share
139P
13) Date of transaction
21/05/02
14) Date company informed
21/05/02
15) Total holding following this notification
5,000
16) Total percentage holding of issued class following this notification
0.01%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number.
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
S D EVANS
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 21ST MAY 2002
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
DECHRA PHARMACEUTICALS PLC
2) NAME OF DIRECTOR
SIMON EVANS
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
AS ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
AS ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
PURCHASE OF SHARES
7) Number of shares/amount of
stock acquired
25,000
8) (0.05%)
of issued Class
9) Number of shares/amount
of stock disposed
N/A
10) ( N/A %)
of issued Class
11) Class of security
ORDS OF 1P
12) Price per share
139P
13) Date of transaction
21/05/02
14) Date company informed
21/05/02
15) Total holding following this notification
663,000
16) Total percentage holding of issued class following this notification
1.32%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number.
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
S D EVANS
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 21ST MAY 2002
This information is provided by RNS
The company news service from the London Stock Exchange
Latest directors dealings
- 3 hours ago Luceco
- 3 hours ago Helios Towers
- 3 hours ago Wise Class A
- 3 hours ago EDX Medical Group Plc
- 4 hours ago Naked Wines